05/08/2025
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
4:00 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/28/2025
4:00 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/28/2025
4:05 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
03/18/2025
7:30 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:05 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:05 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:32 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IOVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/05/2025
7:32 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:33 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:30 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:31 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
4:15 PM | Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
4:17 PM | Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:22 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
4:59 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:00 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:15 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/02/2024
4:25 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 PM | Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
8:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
7:38 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
5:30 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:32 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:33 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:52 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:54 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:56 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:10 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024
7:00 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. |
07/17/2024
7:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:00 PM | Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:00 PM | Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:01 PM | Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:02 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:03 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
7:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:04 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:05 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
